iCo Therapeutics recruiting for Phase II DME study
iCo Therapeutics Inc., a Vancouver based reprofiling development company, have announced their intention to recruit patients for a Phase II DME clinical trial of their… Read More »iCo Therapeutics recruiting for Phase II DME study